• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Drug-induced alopecia after dupilumab therapy.

作者信息

Flanagan Kathleen, Sperling Leonard, Lin Janet

机构信息

US Dermatology Partners, Rockville, Maryland.

University of Uniformed Health Services Department of Dermatology, Bethesda, Maryland.

出版信息

JAAD Case Rep. 2018 Dec 6;5(1):54-56. doi: 10.1016/j.jdcr.2018.10.010. eCollection 2019 Jan.

DOI:10.1016/j.jdcr.2018.10.010
PMID:30560185
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6289959/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5182/6289959/21ec0c45ca9d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5182/6289959/3f761afced02/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5182/6289959/cc9deb0c41fa/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5182/6289959/ad1c865def53/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5182/6289959/21ec0c45ca9d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5182/6289959/3f761afced02/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5182/6289959/cc9deb0c41fa/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5182/6289959/ad1c865def53/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5182/6289959/21ec0c45ca9d/gr4.jpg

相似文献

1
Drug-induced alopecia after dupilumab therapy.度普利尤单抗治疗后药物性脱发
JAAD Case Rep. 2018 Dec 6;5(1):54-56. doi: 10.1016/j.jdcr.2018.10.010. eCollection 2019 Jan.
2
Alopecia areata after dupilumab for atopic dermatitis.度普利尤单抗治疗特应性皮炎后出现斑秃。
JAAD Case Rep. 2018 Jan 16;4(2):143-144. doi: 10.1016/j.jdcr.2017.11.020. eCollection 2018 Mar.
3
Remission of alopecia universalis in a patient with atopic dermatitis treated with dupilumab.使用度普利尤单抗治疗的特应性皮炎患者泛发性斑秃缓解。
JAAD Case Rep. 2019 Jan 12;5(2):116-117. doi: 10.1016/j.jdcr.2018.11.007. eCollection 2019 Feb.
4
Full scalp hair regrowth in a 4-year-old girl with alopecia areata and atopic dermatitis treated with dupilumab.用度普利尤单抗治疗的一名患有斑秃和特应性皮炎的4岁女孩头皮毛发完全再生。
JAAD Case Rep. 2020 Oct 15;6(12):1286-1287. doi: 10.1016/j.jdcr.2020.10.010. eCollection 2020 Dec.
5
Ophiasis treated with dupilumab.用度普利尤单抗治疗的匐行性脱发。
JAAD Case Rep. 2021 Aug 19;16:1-4. doi: 10.1016/j.jdcr.2021.07.029. eCollection 2021 Oct.
6
Improvement of atopic dermatitis and alopecia universalis with dupilumab.度普利尤单抗治疗特应性皮炎和泛发性斑秃的疗效观察
Dermatol Reports. 2021 Dec 28;14(2):9359. doi: 10.4081/dr.2022.9359. eCollection 2022 Jun 16.
7
Dupilumab after the 2017 approval for the treatment of atopic dermatitis: what's new and what's next?2017 年批准用于治疗特应性皮炎后dupilumab 的新进展：有哪些新进展和下一步计划？
Curr Opin Allergy Clin Immunol. 2019 Aug;19(4):341-349. doi: 10.1097/ACI.0000000000000551.
8
[Dupilumab-Associated Healing of Alopecia Areata in an Atopic Dermatitis Patient].[特应性皮炎患者中与度普利尤单抗相关的斑秃愈合情况]
Dtsch Med Wochenschr. 2019 May;144(9):602-605. doi: 10.1055/a-0836-3119. Epub 2019 Apr 26.
9
Dupilumab side effect in a patient with atopic dermatitis: a case report study.度普利尤单抗在一名特应性皮炎患者中的副作用：一项病例报告研究。
Biologics. 2019 May 13;13:79-82. doi: 10.2147/BTT.S195512. eCollection 2019.
10
Resolution of dupilumab-associated alopecia areata with dosage modification.通过调整度普利尤单抗剂量使斑秃得到缓解。
JAAD Case Rep. 2022 Feb 17;22:85-88. doi: 10.1016/j.jdcr.2022.01.034. eCollection 2022 Apr.

引用本文的文献

1
Alopecia Areata: Pathogenesis, Diagnosis, and Therapies.斑秃：发病机制、诊断与治疗
MedComm (2020). 2025 Apr 21;6(5):e70182. doi: 10.1002/mco2.70182. eCollection 2025 May.
2
Dupilumab and Alopecia Areata: A Possible Combined or Disturbance Therapy? A Review of The Literature.度普利尤单抗与斑秃：一种可能的联合治疗或干扰治疗？文献综述
Dermatol Pract Concept. 2024 Oct 30;14(4):e2024270. doi: 10.5826/dpc.1404a270.
3
Real-World Safety Profile of Biologic Drugs for Severe Uncontrolled Asthma: A Descriptive Analysis from the Spanish Pharmacovigilance Database.

本文引用的文献

1
Dual efficacy of dupilumab in a patient with concomitant atopic dermatitis and alopecia areata.度普利尤单抗对一名同时患有特应性皮炎和斑秃患者的双重疗效。
Br J Dermatol. 2018 Aug;179(2):534-536. doi: 10.1111/bjd.16711. Epub 2018 Jun 15.
2
Alopecia areata after dupilumab for atopic dermatitis.度普利尤单抗治疗特应性皮炎后出现斑秃。
JAAD Case Rep. 2018 Jan 16;4(2):143-144. doi: 10.1016/j.jdcr.2017.11.020. eCollection 2018 Mar.
3
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.两项度普利尤单抗治疗特应性皮炎的 3 期临床试验。
生物制剂治疗重度难治性哮喘的真实世界安全性概况：来自西班牙药物警戒数据库的描述性分析
J Clin Med. 2024 Jul 18;13(14):4192. doi: 10.3390/jcm13144192.
4
Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?与1型相关皮肤炎症性疾病相关的2型免疫：是友还是敌？
Front Immunol. 2024 May 29;15:1405215. doi: 10.3389/fimmu.2024.1405215. eCollection 2024.
5
Long-term, observational, real-world study of dupilumab for the treatment of moderate-to-severe atopic dermatitis: a 52-week single-center retrospective analysis in China.长期、观察性、真实世界研究：度普利尤单抗治疗中重度特应性皮炎——中国 52 周单中心回顾性分析。
Arch Dermatol Res. 2024 May 31;316(6):304. doi: 10.1007/s00403-024-03029-6.
6
TNF-like weak inducer of apoptosis inhibition is comparable to IL-13 blockade in ameliorating atopic dermatitis inflammation.TNF 样凋亡弱抑制剂在改善特应性皮炎炎症方面与 IL-13 阻断相当。
Allergy. 2024 Jan;79(1):116-127. doi: 10.1111/all.15879. Epub 2023 Aug 31.
7
Short communication: Comments on hair disorders associated with dupilumab based on VigiBase.短篇通讯：基于 VigiBase 的有关度普利尤单抗相关毛发疾病的评论。
PLoS One. 2022 Jul 27;17(7):e0270906. doi: 10.1371/journal.pone.0270906. eCollection 2022.
8
Long-Term Efficacy of Dupilumab in Alopecia Areata.斑秃患者使用度普利尤单抗的长期疗效。
Am J Case Rep. 2022 Jun 21;23:e936488. doi: 10.12659/AJCR.936488.
9
Resolution of dupilumab-associated alopecia areata with dosage modification.通过调整度普利尤单抗剂量使斑秃得到缓解。
JAAD Case Rep. 2022 Feb 17;22:85-88. doi: 10.1016/j.jdcr.2022.01.034. eCollection 2022 Apr.
10
Remission of Alopecia Universalis after 1 Year of Treatment with Dupilumab in a Patient with Severe Atopic Dermatitis.度普利尤单抗治疗1年后，重度特应性皮炎患者泛发性斑秃缓解
Skin Appendage Disord. 2022 Jan;8(1):38-41. doi: 10.1159/000517832. Epub 2021 Jul 27.
N Engl J Med. 2016 Dec 15;375(24):2335-2348. doi: 10.1056/NEJMoa1610020. Epub 2016 Sep 30.
4
Cellular and molecular immunologic mechanisms in patients with atopic dermatitis.特应性皮炎患者的细胞和分子免疫机制。
J Allergy Clin Immunol. 2016 Aug;138(2):336-49. doi: 10.1016/j.jaci.2016.06.010.
5
Sebaceous Gland Atrophy in Psoriasis: An Explanation for Psoriatic Alopecia?银屑病中的皮脂腺萎缩：银屑病性脱发的一种解释？
J Invest Dermatol. 2016 Sep;136(9):1792-1800. doi: 10.1016/j.jid.2016.05.113. Epub 2016 Jun 14.
6
Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing.斑秃特征分析显示 TH1、TH2 和 IL-23 细胞因子激活，而无平行的 TH17/TH22 偏倚。
J Allergy Clin Immunol. 2015 Nov;136(5):1277-87. doi: 10.1016/j.jaci.2015.06.032. Epub 2015 Aug 24.
7
Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.度普利尤单抗治疗中重度特应性皮炎成人患者。
N Engl J Med. 2014 Jul 10;371(2):130-9. doi: 10.1056/NEJMoa1314768.
8
Psoriatic alopecia/alopecia areata-like reactions secondary to anti-tumor necrosis factor-α therapy: a novel cause of noncicatricial alopecia.抗肿瘤坏死因子-α治疗继发的银屑病性脱发/斑秃样反应：非瘢痕性脱发的新病因
Am J Dermatopathol. 2011 Apr;33(2):161-6. doi: 10.1097/DAD.0b013e3181ef7403.
9
Possible pathogenic role of Th17 cells for atopic dermatitis.Th17细胞在特应性皮炎中可能的致病作用。
J Invest Dermatol. 2008 Nov;128(11):2625-2630. doi: 10.1038/jid.2008.111. Epub 2008 Apr 24.